Fidelity Investments’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.4M Buy
3,157,639
+44,827
+1% +$1.47M ﹤0.01% 1232
2025
Q4
$116M Sell
3,112,812
-734,160
-19% -$24.1M 0.01% 1106
2025
Q3
$106M Sell
3,846,972
-841,220
-18% -$29M 0.01% 1157
2025
Q2
$148M Sell
4,688,192
-654,333
-12% -$21M 0.01% 949
2025
Q1
$177M Buy
5,342,525
+12,623
+0.2% +$453K 0.01% 840
2024
Q4
$183M Buy
5,329,902
+101,182
+2% +$3.48M 0.01% 858
2024
Q3
$209M Sell
5,228,720
-9,184
-0.2% -$323K 0.01% 811
2024
Q2
$158M Sell
5,237,904
-17,614
-0.3% -$530K 0.01% 869
2024
Q1
$176M Sell
5,255,518
-21,307
-0.4% -$684K 0.01% 838
2023
Q4
$170M Sell
5,276,825
-173,384
-3% -$4.84M 0.01% 808
2023
Q3
$179M Sell
5,450,209
-20,038
-0.4% -$696K 0.02% 739
2023
Q2
$192M Sell
5,470,247
-121,328
-2% -$4.19M 0.02% 737
2023
Q1
$183M Buy
5,591,575
+8,847
+0.2% +$403K 0.02% 745
2022
Q4
$308M Sell
5,582,728
-32,611
-0.6% -$1.79M 0.03% 550
2022
Q3
$249M Buy
5,615,339
+188,557
+3% +$9.2M 0.03% 594
2022
Q2
$265M Buy
5,426,782
+529,600
+11% +$23.8M 0.03% 605
2022
Q1
$238M Buy
4,897,182
+689,583
+16% +$28.1M 0.02% 697
2021
Q4
$179M Buy
4,207,599
+78,648
+2% +$3.13M 0.01% 847
2021
Q3
$158M Sell
4,128,951
-812,576
-16% -$26.2M 0.01% 908
2021
Q2
$139M Sell
4,941,527
-2,308,914
-32% -$69.3M 0.01% 981
2021
Q1
$240M Sell
7,250,441
-676,183
-9% -$23.7M 0.02% 712
2020
Q4
$274M Sell
7,926,624
-1,137,412
-13% -$45.9M 0.02% 622
2020
Q3
$280M Buy
+9,064,036
New +$330M 0.03% 512

Other funds holding HRMY